HSTM Stock Analysis: Buy, Sell, or Hold?
HSTM - HealthStream Inc
$25.36
-0.28 (-1.09%)
▼
5d:
-2.95%
30d:
+6.02%
90d:
+24.68%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When HSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HSTM shows positive signals but monitor for confirmation. Market pricing in 3.5% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: HSTM shows positive signals but monitor for confirmation. Market pricing in 3.5% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.44
Based on 7.1% avg growth
INTRINSIC VALUE TODAY
$18.90
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSTM is currently trading at $25.36, which is considered fair relative to its 30-day fair value range of $24.07 to $25.96. From a valuation perspective, the stock is trading at a premium (Forward PE: 29.3) compared to its historical average (26.5). At these levels, the market is pricing in 3.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HSTM is in a strong uptrend. The price is currently testing key support at $25.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.00 (+26.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSTM is in a strong uptrend. The price is currently testing key support at $25.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.00 (+26.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$24.07 -
$25.96
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.3%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.2% below Wall St target ($32.00)
- NEUTRAL: Market pricing in 3.5% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$24.07 -
$25.96
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$25.28
Resistance Level
$26.76
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
29.32
Wall Street Target
$32.00
(+26.2%)
Revenue Growth (YoY)
10.5%
Earnings Growth (YoY)
42.9%
Profit Margin
6.4%
Valuation Premium vs History
+3.5% premium
PE vs Historical
29.3 vs 26.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.5%
(market-implied from PE analysis)
1-Year Target
$26.25
(+4%)
2-Year Target
$27.17
(+7%)
3-Year Target
$28.12
(+11%)
3-Yr Target (if PE normalizes)
(PE: 29→27)
PE COMPRESSION
$25.41
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.3, Growth: 10.2%)
$33.93
(+34%)
Base:
(SPY PE: 21.8, Growth: 10.2%)
$25.21
(-1%)
Bear:
(PE: 18.5, Growth: 10.2%)
$21.43
(-16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (29x PE) as earnings recover.
Trailing PE: 38.27 | Current EPS (TTM): $0.67
Bull Case
$36.41
(+44%)
Analyst growth 29.1%, PE expands to 42.1
Base Case
$33.10
(+31%)
Market implied 29.1%, PE stable at 38.3
Bear Case
$17.44
(-31%)
Severe decline -20.0%, PE contracts to 32.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 9:02 AM ET
Data refreshes hourly during market hours. Next update: 10:02 AM
Data refreshes hourly during market hours. Next update: 10:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 57 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 55 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$34 | 55 HOLD |
